MedRx Co. Ltd. announced consolidated financial results for the six months ended June 30, 2016. For the six months, the company reported operating loss of ¥742 million and loss attributable to owners of parent of ¥707 million or ¥92.1 per share on net sales of ¥10 million against operating loss of ¥446 million and loss attributable to owners of parent of ¥336 million or ¥50.32 per share on net sales of ¥15 million for the same period of last year.

For the year ending Dec. 2016, the company expects, operating loss of ¥1,608 million and loss attributable to owners of parent of ¥1,572 million or ¥196.9 per share on net sales of ¥29 million.